NFE2L2 and acute respiratory distress syndrome: Nrf2 activator isoliquiritigenin prevents the development of ALI in mice by suppressing the NF-κB pathway through induction expression of Nrf2 and adenosine monophosphate protein kinase (AMPK) (Liu et al. 2017a).